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Bifidobacterium pseudocatenulatum CECT 7765 was isolated from stools of a breast-
fed infant. Although, this strain is generally considered an adult-type bifidobacterial
species, it has also been shown to have pre-clinical efficacy in obesity models. In
order to understand the molecular basis of its adaptation to complex carbohydrates
and improve its potential functionality, we have analyzed its genome and transcriptome,
as well as its metabolic output when growing in galacto-oligosaccharides derived
from lactulose (GOS-Lu) as carbon source. B. pseudocatenulatum CECT 7765 shows
strain-specific genome regions, including a great diversity of sugar metabolic-related
genes. A preliminary and exploratory transcriptome analysis suggests candidate over-
expression of several genes coding for sugar transporters and permeases; furthermore,
five out of seven beta-galactosidases identified in the genome could be activated in
response to GOS-Lu exposure. Here, we also propose that a specific gene cluster
is involved in controlling the import and hydrolysis of certain di- and tri-saccharides,
which seemed to be those primarily taken-up by the bifidobacterial strain. This was
discerned from mass spectrometry-based quantification of different saccharide fractions
of culture supernatants. Our results confirm that the expression of genes involved in
sugar transport and metabolism and in the synthesis of leucine, an amino acid with a key
role in glucose and energy homeostasis, was up-regulated by GOS-Lu. This was done
using qPCR in addition to the exploratory information derived from the single-replicated
RNAseq approach, together with the functional annotation of genes predicted to be
encoded in the B. pseudocatenulatum CETC 7765 genome.
Keywords: Bifidobacterium pseudocatenulatum CECT7765, transcriptome, lactulose-oligosaccharides,
probiotics, gut microbiota, leucine
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INTRODUCTION
Indigenous intestinal bacteria are known to be equipped with an
array of genes coding for uptake systems and complex enzymatic
machinery that facilitates the utilization of oligo- and poly-
saccharides. This constitutes a major adaptation mechanism
to the main energy sources available in the large intestine
for symbiotic bacteria (Jost et al., 2015). The role of breast-
feeding in defining the composition of the gut microbiota,
characterized by the dominance of bifidobacteria in infants,
constitutes the best example of this adaptation process (Penders
et al., 2006; Palma et al., 2012; Olivares et al., 2014). Human
milk oligosaccharides are highly diverse and complex glycans,
which seem to have evolved naturally, shaping the species
that inhabit the infant gut (Koropatkin et al., 2012). Thus,
species of the genus Bifidobacterium that predominate in breast-
fed babies (B. longum subsp. infantis and B. bifidum, the
so-called infant-type bifidobacteria) are known to possess the
genetic and protein machinery (oligosaccharide binding proteins,
fucosidases, lacto-N biosidase, etc.) necessary to utilize human-
milk oligosaccharides. This confers a competitive advantage to
bifidobacteria, whereby they outnumber other intestinal bacteria
(Yoshida et al., 2012; Garrido et al., 2013; Viborg et al., 2014).
This adaptation to diet may, in turn, also define the symbiotic
host–microbe interactions and their biological role in human
health (Sanz, 2015). Epidemiological studies have demonstrated
that breast-feeding confers benefits for early and long-term
health, improving intestinal transit and reducing the incidence
of infections and non-communicable diseases (e.g., obesity and
type-2 diabetes; reviewed by Sanz, 2015). It is not easy to confirm
whether these effects are a direct consequence of the human-
milk-induced microbiota pattern; however, it is biologically
plausible that bifidobacteria play a potential role, which is
supported to some extent by existing clinical (Braegger et al.,
2011; Miller and Ouwehand, 2013; Sanz, 2015) and pre-clinical
data (Cano et al., 2013; Hayes et al., 2014; Moya-Perez et al.,
2014, 2015; Reichold et al., 2014; Elian et al., 2015; Srutkova
et al., 2015). Consequently, alternative oligosaccharides have been
produced to try to mimic the role of human milk oligosaccharides
in the infant’s microbiota, as well as to exert “bifidogenic”
effects in adults, in the form of food ingredients or supplements
(Marriage et al., 2015). Among these, long-chain inulin-type
fructans (FOS) and short-chain galacto-oligosaccharides (GOS)
are the most commonly used, particularly in infant formula
attempting to provide the beneficial effects of breast-milk (Oozeer
et al., 2013). Nevertheless, further research is required to
develop oligosaccharides that more closely resemble their natural
counterparts, and to shed light on their interactions with specific
indigenous bacteria, as well as their health consequences.
Studies in vivo reveal that lactulose-derived GOS (GOS-
Lu) have higher resistance to gastrointestinal digestion and
less absorption in the small intestine of rats than GOS
derived from lactose. These properties were attributed to
the strong resistance of galactosyl-fructoses to the hydrolytic
action of mammalian digestive enzymes (Hernandez-Hernandez
et al., 2012b). Conventional GOS (derived from lactose) and
GOS-Lu bear different structural features based not only
on monosaccharide composition but also on the degree of
polymerization, anomeric configuration, isomer composition
and types of glycosidic linkage. Specifically, the predominant
glycosidic linkage type in GOS-Lu is β-(1→6), whereas the
main glycosidic linkage present in commercial GOS is β-(1→4)
for instance Vivinal R© (Friesland Campina, The Netherlands).
Additionally, GOS-Lu also contains galactosyl-fructoses and
galactobioses containing 1→2 and 1→5 linkages, which are
not found in conventional GOS. These differences in glycosidic
linkage types are thought to be crucial in the potential bioactivity
of GOS-Lu type oligosaccharides.
In this study, we have investigated the ability of
Bifidobacterium pseudocatenulatum CECT 7765, isolated from
stools of a breast-fed infant, to utilize galacto-oligosaccharides.
This is the first attempt to understand its origin, as this is
generally considered to be an adult-type bifidobacterium, and to
improve its functionality as a potential probiotic, bearing in mind
this strain has proven pre-clinical efficacy in obesity and cirrhosis
experimental models (Cano et al., 2013; Moya-Perez et al., 2014,
2015). In addition, we have evaluated the potential advantage
of using a GOS-Lu instead of a GOS because of its persistence
in the intestine and slower fermentation in proximal colon
(Cardelle-Cobas et al., 2008; Martinez-Villaluenga et al., 2008;
Hernandez-Hernandez et al., 2012b), as well as its capacity to
selectively stimulate the growth and/or activity of bifidobacterial
species (Marin-Manzano et al., 2013). Previous research also
shows GOS-Lu are effective in a rat model of experimental
colitis, presumably by exerting immunomodulatory effects
associated with increased short-chain fatty-acid production
(Algieri et al., 2014). Additionally, the presence of non-
transgalactosylated lactulose, a prebiotic, instead of lactose in the
GOS-Lu mixture could also provide additional benefits such as a
lower calorific content than conventional GOS or other beneficial
properties attributed to lactulose (Cardelle-Cobas et al., 2008;
Martinez-Villaluenga et al., 2008).
To address this study, we have investigated the molecular
response of B. pseudocatenulatum CECT 7765 when cultured in
the presence of either glucose or GOS-Lu as carbon source. To
do so, we have used three different high-throughput approaches:
(i) genomic DNA sequencing for whole-genome assembly and
functional annotation of the strain studied; (ii) a preliminary
and exploratory single-replicated transcriptome approach of
RNA pools to detect potential signals of over-expression across
the B. pseudocatenulatum CETC 7765 genome during GOS-Lu
fermentation, followed by validation of certain gene expression
patterns by qPCR; and (iii) metabolite analysis of GOS-Lu species
using gas chromatography coupled to mass spectrometry (GC–
MS) to understand the upregulated metabolic pathways, the final
output and potential biological consequences.
MATERIALS AND METHODS
Enzymatic Synthesis of GOS-Lu
GOS-Lu were enzymatically synthesized via hydrolysis
and transgalactosylation of lactulose (Duphalac R©, Solvay
Pharmaceuticals, Weesp, Holland) using a β-galactosidase from
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Aspergillus oryzae and following previously described methods
(Clemente et al., 2011). Then, the GOS-Lu mixture was treated
with activated charcoal to remove the monosaccharide fraction
(Hernandez et al., 2009). The final GOS-Lu composition was:
72% carbohydrates, 15% water, and 10% mineral salts. According
to previous ESI-MS analysis, GOS-Lu predominantly consisted
of di- and tri-saccharides (42 and 31% of total carbohydrates,
respectively), followed by tetra- and penta-saccharides (25% of
total carbohydrates), whereas only 2% were monosaccharides
(Marin-Manzano et al., 2013).
Bacterial Growth
Bifidobacterium pseudocatenulatum CECT 7765 was isolated
from a breast-fed infant subject of a prospective observational
study carried out in a cohort of 164 healthy full-term newborns,
with a first degree relative affected by celiac disease. Ethics
committee approvals for that study, according to the Helsinki
Declaration of 1983, are already published (Palma et al., 2012).
B. pseudocatenulatum CECT 7765 was grown overnight in
low glucose modified MRS broth (10 g/L peptone, 8 g/L
meat extract, 4 g/L yeast extract, 5 g/L sodium acetate, 2 g/L
di-ammonium citrate, 0.2 g/L magnesium sulfate, 0.05 g/L
manganesum sulfate, 2 g/L di-potassium phosphate, 0.1% v/v
polysorbate 80) supplemented with 0.05% (w/v) L-cysteine
and 0.5% (w/v) glucose at 37◦C under anaerobic conditions
into Whitley DG250 Anaerobic Workstation (don Whitley
Scientific, Inc., Shipley, UK). A 5 mL aliquot of an overnight
culture was obtained for genomic DNA isolation. For RNA
isolation, over-day cultures were obtained by refreshing 1/100
overnight cultures in pre-warmed and oxygen-depleted modified
MRS media supplemented with 0.05% (w/v) L-cysteine and
containing 1% (w/v) glucose or 1% (w/v) GOS-Lu as sole
carbon sources. Early exponential growth phase cultures were
collected after 7–8 h of incubation, when optical density at
600 nm (OD 600) was approximately 0.4, to optimally detect
differential gene expression patterns, as previously described
(Garrido et al., 2012), and to measure the residual fraction of
GOS-Lu components. Stationary growth phase cultures were
collected to measure accumulation of branched-chain amino
acids in cell-free culture supernatants by LC with fluorescence
detection. In both cases, cells were pelleted by centrifuging
at 4◦C and 2,500 × g for 20 min, and supernatants were
aspired off and filtered using 0.22 µm disposable filters
(Millipore).
Nucleic Acid Isolation
DNA and RNA from respective bacterial cultures were isolated
using MasterPureTM Gram Positive DNA Purification Kit
(Epicentre) with slight variations over manufacturer’s
instructions. Briefly, a cell lysis step was improved by
incubating cell suspension with 500 µg Lysozyme (Sigma,
Cat #62970) and 20 U Mutanolysin (Sigma, Cat #M9901)
for 60 min at 37◦C. For DNA isolation, samples were
incubated with RNase A at 37◦C for 60 min, whereas for
RNA isolation samples were incubated with 2 U DNase
I (Epicentre) at 37◦C for 60 min instead of the RNase A
treatment.
High-Throughput Sequencing
Ten µg genomic DNA from B. pseudocatenulatum CECT 7765
were sent to Eurofins Genomics GmbH (Ebersberg, Germany)
to produce a shotgun library by fragmentation and end repair
of DNA with an insert size of 300–400 bp and 2 bp × 150 bp
(paired-end) configuration. The preliminary and exploratory
transcriptome analysis was achieved by pooling RNA from three
independent experiments in an equimolar mixture of glucose- or
GOS-Lu-derived samples, respectively. Then, 30 µg total RNA
per pool were also sent to Eurofins Genomics GmbH (Ebersberg,
Germany) to produce cDNA libraries with an insert size of 150–
400 bp and prior rRNA depletion using RiboZeroTM Magnetic
Kit Gram-Positive Bacteria (Epicentre). DNA and cDNA libraries
were pooled and sequenced in one MiSeq cell flow allowing 1/10
proportion of DNA library against cDNA libraries.
Data Analysis
The B. pseudocatenulatum CECT 7765 genome was assembled
using the MIRA assembler (Chevreux et al., 1999). Scaffolding of
contigs was assisted by SSPACE (Boetzer et al., 2011) and scaffold
reordering was predicted by using comparative genomics and
whole-genome alignment algorithms implemented in MAUVE
(Darling et al., 2010) and draft genomes of close species
such as B. pseudocatenulatum DSM 20438 (Accession number
NZ_ABXX02000001). Predicted joints were corroborated by
PCR and Sanger sequencing. Gene prediction and functional
annotation were performed using tRNAscan-SE (Lowe and
Eddy, 1997), RNAmmer (Lagesen et al., 2007), Prodigal (Hyatt
et al., 2010), KEGG Automatic Annotation System (Moriya
et al., 2007), SMART database (Letunic et al., 2012), Pfam
database (Finn et al., 2014), CAZy database (Lombard et al.,
2014), CAT server (Park et al., 2010), ScanProsite (de Castro
et al., 2006), and Artemis (Rutherford et al., 2000). Sequence
information supporting the B. pseudocatenulatum CECT 7765
genome assembly was submitted to the European Nucleotide
Archive (ENA) where it is publicly available under primary
accession number PRJEB6926. Annotated 5S, 16S, and 23S
rRNA gene sequences from B. pseudocatenulatum CECT
7765 are publicly available under ENA accession numbers
LN624223, LN624224, and LN624525, respectively. Comparative
genomics among Bifidobacterium species was accomplished
using BRIG (Alikhan et al., 2011) and available and complete
genome information from B. breve UCC2003 (NC_020517.1),
B. dentium Bd1 (NC_013714.1), B. longum subsp. infantis ATCC
15697 (NC_017219.1), and B. pseudocatenulatum DSM 20438
(NZ_ABXX02000001, draft genome). The quality filtering and
trimming of glucose- and GOS-Lu-derived RNA-seq analysis was
performed using FASTX-toolkit1. Read mapping was assisted
using the local alignment Blast algorithm (Altschul et al., 1990)
and selecting alignments>50% of read length (>70 nt) and 100%
identity. Read counts were normalized using RPKM (Mortazavi
et al., 2008) and the exploratory differential expression among
glucose- and GOS-Lu-derived transcriptomes was measured
with GFOLD. This analysis tool is able to detect potential
trends in gene expression in unreplicated data, requiring further
1http://hannonlab.cshl.edu/fastx_toolkit/
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evaluation by conclusive methods like qPCR (Feng et al., 2012).
In order to increase the stringency for detecting plausible
signals of differential expression, we only selected genes with
GFOLD score ≤ −1 or ≥1. Sequence information supporting
the B. pseudocatenulatum CECT 7765 transcriptome analysis was
submitted to the ENA where it is publicly available under primary
accession number PRJEB6928.
Quantitative PCR
The genes BPSEU7765_0088, BPSEU7765_0773,
BPSEU7765_0523, BPSEU7765_0525, and BPSEU7765_1462
were selected from the preliminary and exploratory RNA-seq
analysis to assess specific changes in expression by qPCR. The
gene-specific oligonucleotides used for this aim are presented in
the Supplementary Table S1. The cDNA was synthesized using
5 µg of total and non-pooled RNA remaining from that used
for the RNAseq approach (three replicates per treatment), and
the High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems) according to the manufacturer’s instructions. The
qPCR reactions were set in 96-well plates using the SYBR
Green I Master Mix (Roche Lifesciences), 0.5 µM of forward
oligonucleotide, 0.25 µM of reverse oligonucleotide, and 1 µL of
the cDNA reaction. All treatment samples were set in triplicate in
the plate and amplified in a LightCycler 480 II with the following
cycling profile: initial incubation at 95◦ for 5 min and 35 cycles of
10 s at 95◦, 20 s at 65◦, and 15 s at 72◦. Finally, the melting curve
was set from 65 to 97◦ with a ramp rate of 0.11◦/s. The expression
level for each gene was measure according to the 11Ct method,
using the expression of the 16S rRNA gene as calibrator, and
expression of glucose samples as reference. RQ values were
finally obtained with calculation of 2−11Ct for all samples and
replicates. Differential expression was assessed by the one-sided
t-test with Welch’s correction supporting pairwise comparisons
between gene expression under glucose and GOS-Lu treatments.
Quantitative Analysis of GOS-Lu
Consumption by GC–MS
Cell-free supernatants of B. pseudocatenulatum CECT 7765
cultures supplemented with GOS-Lu to replace glucose were
obtained and analyzed by GC–MS using a two-step derivatization
procedure (oximation and trimethylsilylation) according
to previous methods (Hernandez-Hernandez et al., 2011).
Trimethylsilyloximes (TMSO) derivatives of carbohydrates
were identified by comparison of mass spectra and retention
indices with standard derivatized carbohydrates, as described
in a previous study (Hernandez-Hernandez et al., 2012a).
Characteristic mass spectra and data previously reported in the
literature were used to identify those carbohydrates unavailable
as commercial standards. Carbohydrate quantitative data were
obtained from GC–MS peak areas using the internal standard
method. To do so, standard solutions from 0.003 to 1 mg of
phenyl-β-D-glucoside, sucrose, and raffinose were prepared to
calculate the corresponding response factors relative to internal
standard and used to quantify mono-, di-, and tri-saccharides,
respectively. Analytical standards of fructose, galactose,
lactulose [β-D-galactopyranosyl-(1→4)-D-fructose], lactose
[β-D-galactopyranosyl-(1→4)-D-glucose], 1,6-galactobiose
[β-D-galactopyranosyl-(1→6)-D-galactose], 1,4-galactobiose [β-
D-galactopyranosyl-(1→4)-D-galactose], and 1,3-galactobiose
[α-D-galactopyranosyl-(1→3)-D-galactose] were obtained from
Sigma (St. Louis, MO, USA).
Quantitative Analysis of Branched-Chain
Amino Acids
For valine (V), isoleucine (I) and leucine (L) analyses, samples
were 1,000-fold diluted with 2 N acetic acid (BDH Prolabo)
and subjected to an automatic pre-column derivatization with
o-phthaldialdehyde (OPA; Sigma-Aldrich). For the derivatization
step, 20 µl of diluted sample was mixed with 15 µl of 4 N
NaOH (BDH Prolabo), 40 µl of OPA and 20 µl of 5% acetic acid
in Milli-Q water and, then, 20 µl of the resulting mixture was
injected into the LC system. Amino acids were separated by LC
Gemini C-18 column (5 µm particle size, 250 mm × 4.6 mm
i.d., Phenomenex) at a flow rate of 1 mL/min and 25◦C. Solvent
A was 0.15 M anhydrous sodium acetate (Sigma-Aldrich)/HPLC
grade methanol (BDH Prolabo; 70:30, v:v) adjusted to pH 6.8
with glacial acetic acid (BDH Prolabo); solvent B was HPLC grade
methanol/Milli-Q water (70:30, v:v). Elution was performed with
a linear gradient as follows: 0–13 min, 50% B; 13–15 min, 100%
B; 15–22 min, 100% B; 22–23 min, 50% B; 23–34 min, 50% B.
Detection was performed by fluorescence using 340 and 455 nm
for excitation and emission, respectively. Calibration curves of
V, I, and L were built using commercial pure standards (0.1–
1 ppm in 2 N acetic acid for I and L; 0.05–1 ppm in 2 N acetic
acid for V) purchased from Sigma-Aldrich. Production of BCAAs
was individually compared (V, I, or L) between treatments (GOS-
Lu vs. Glucose) and differences were statistically analyzed with a
one-sided t-test with Welch’s correction.
RESULTS
B. pseudocatenulatum CECT 7765
Genome
The draft genome of B. pseudocatenulatum CECT 7765
comprised ∼2.25 Mbp containing six major super-scaffolds
(ENA accession numbers: CDPW01000001 to CDPW01000006)
with a 56.4% GC content, assembled from 138 contigs with
N50 ∼145,000 bp and a theoretical coverage of 93X (MIRA
assembler). At final assembly stage, the total number of genes
predicted to be encoded by the B. pseudocatenulatum CECT
7765 genome was 1,879. Of these, 1,821 corresponded to
coding genes, 54 tRNA genes, three rRNA genes clustered
in a single operon, and one tRNA pseudogene with a
CAT anticodon. This genome structure is quite similar to
others from B. psudocatenulatum species recently sequenced
(Alegria et al., 2014). Additionally, a Clustered Regularly
Interspaced Short Palindromic Repeats (CRISPRs) region
was predicted. This region is characterized by 57 repeats
of the ATTTCAATCCACGCTCTCCATGAGGAGAGCGAC
sequence and a CRISPR-associated gene (Cas) annotated
as BPSEU7765_1382 gene immediately downstream of the
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FIGURE 1 | Comparative analysis of Bifidobacterium pseudocatenulatum CECT 7765 and close species. Circular representation of B. pseudocatenulatum
CECT 7765 (black inner line), B. pseudocatenulatum DSM 20438 (purple), B. dentium Bd1 (red), B. breve UCC2003 (blue), and B. longum subsp infantis ATCC
15697 (green) genomes. They are compared using whole-genome and blast-based alignment. Genomic regions exclusively found on B. pseudocatenulatum CECT
7765 are highlighted with dashed rectangles with functional annotation of genes present alongside, respectively.
repetitive region. This feature indicates that
B. pseudocatenulatum CECT 7765 can defend against
bacteriophage attack with its innate immune system (Bhaya
et al., 2011). Ribosomal RNA sequence information is publicly
available in the ENA under accession numbers LN624223
to LN624225 for 5S, 16S, and 23S molecules, respectively.
When the complete genomes (except for B. pseudocatenulatum
DSM 20438) of representative species of the Bifidobacterium
genus were compared, we could distinguish certain genomic
regions differentially present in B. pseudocatenulatum CECT
7765 that are absent in other species, and even in one
strain of the same species, B. pseudocatenulatum DSM
20438 (Figure 1). Consequently, we could distinguish six
different genomic regions entirely and uniquely present in
B. pseudocatenulatum CECT 7765, called Specificity Islands
(SP1 to SP6) hereinafter. Functional analyses were made to
disclose the potential gain-of-function in B. pseudocatenulatum
CECT 7765 genome. In general terms, we found that
functions distinctively found in the B. pseudocatenulatum
CECT 7765 SPs were related to bacterial defense, and to
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carbohydrate transport and metabolism (Figure 1), and
were sometimes duplicated. For instance, SP1 and SP2 show
duplication in the cluster conformed by genes encoding DNA
methylase, HTH_Tnp transposase and RelB antitoxin protein.
These duplication events can be explained by the potential
presence of transposases, predicted to be encoded in the
respective SPs.
As stated above, we observed a predominant gain of defense
genes such as DNA methylases, restriction enzyme systems, and
abortive phage infection proteins in the B. pseudocatenulatum
CECT 7765 genome. Furthermore, there was a great variety of
enzymes associated with carbohydrate metabolism and transport.
Among them, we could distinguish genes coding for different
metabolic functions such as glucosyltransferases, polysaccharide
synthases, peptidoglycan-associated polymer synthases, and
mono- (glucose and rhamnose) and tri-saccharide (raffinose)
hydrolases, as well as multiple sugar transporters. Globally, the
genome structure suggests that B. pseudocatenulatum CECT
7765 is strongly protected against phage infection by restriction
modification systems located at SP2 (Figure 1), identified
with locus tags BPSEU7765_0786 to BPSEU7765_0788, which
account for a type I system with M, S, and R subunits,
respectively. They appear to be additional to three other
restriction modification systems, identified with locus tags
BPSEU7765_708 to BPSEU7765_710 (type I), BPSEU7765_1106
(mrr protein of type IV system), and BPSEU7765_1110 to
BPSEU7765_1112 (type III). Besides these bacterial immune
system genes, we have also identified a CRISPR locus and a gene
encoding a protein associated with the ability to abort active
phage infections, the Abi protein (locus tag BPSEU7765_1115),
previously reported in Lactococcus species (Anba et al., 1995;
Garvey et al., 1995). Furthermore, B. pseudocatenulatum
CECT 7765 seems to have a wide repertoire of genes
involved in mono-, oligo-, and poly-saccharide metabolism,
which could facilitate its survival in the large intestine
where complex oligosaccharides are the main energy source.
To better understand the potential of B. pseudocatenulatum
CECT 7765 to metabolize a wide variety of oligo- and
poly-saccharides, we have annotated all its genes encoding
active enzymes of the carbohydrate metabolism, according
to CAZy database (Lombard et al., 2014). Subsequently, we
submitted the 1,821 ORF sequences, translated into amino
acids, to the CAT server (Park et al., 2010). Thus, we have
obtained 252 enzymes annotated with the CAZy system,
encoded by the B. pseudocatenulatum CECT 7765 chromosome.
A comparative analysis indicates that the CAZy enzymes present
in B. pseudocatenulatum CECT 7765 outnumber those present
in B. dentium Bd1 (128 CAZy enzymes), B. breve UCC2003
(83), B. longum ATCC 15697 (70), and B. pseudocatenulatum
DSM 20438 (97), all of which are fully annotated in the
CAZy database. We detected the specific group of enzymes
exclusively present in B. pseudocatenulatum CECT 7765 by
drawing Venn diagrams (Bardou et al., 2014) and disclosing
the intersection lists of enzymes (Figure 2A). Consequently,
we found that 33 CAZy families were exclusively found in
B. pseudocatenulatum CECT 7765, whose associated functions
are shown in Table 1.
FIGURE 2 | Bifidobacterium pseudocatenulatum CECT 7765 and
carbohydrate metabolism. (A) Venn diagram showing the strain-specific
and shared CAZy families among five Bifidobacterium species. (B) Growth
curve comparison between B. pseudocatenulatum CECT 7765 cultures using
Glucose (blue line) or GOS-Lu (red line) as carbon source. Growth was
monitored measuring OD600 at 60 min intervals. The OD600 values are
presented as a mean of three independent replicates (±SEM). The dashed
square indicates the growth window for the exploratory transcriptome and
qPCR analyses.
The above results indicate that B. pseudocatenulatum CECT
7765 should be able to grow in the presence of a wide
variety of carbon sources. This assumption was reflected in
the fact it thrived on media supplemented with GOS-Lu
instead of glucose (Figure 2B). Indeed, the doubling time
(time to double the OD600 absorbance) at the exponential
growth phase was slightly lower in the presence of GOS-
Lu than in the presence of glucose (73.3 ± 3.8 min vs.
76.1 ± 0.7, respectively, p = 0.48). The ease with which it
utilizes this prebiotic substrate seems to be a particular feature
of this strain, not exhibited by other Bifidobacterium strains
when cultured with GOS as carbon source (Marcobal et al.,
2010; Garrido et al., 2013; Watson et al., 2013). The species
B. pseudocatenulatum has traditionally been considered an adult-
type bifidobacteria, unlike B. breve and B. longum subsp. infantis,
which are considered infant-type bifidobacteria (Pozo-Rubio
et al., 2011). Nevertheless, B. pseudocatenulatum CECT 7765
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TABLE 1 | CAZy-based functional annotation of Bifidobacterium pseudocatenulatum CECT 7765 enzyme.
CAZy family Gene tag Functional annotation EC number
CBM27 BPSEU7765_0090, BPSEU7765_0322,
BPSEU7765_0461, BPSEU7765_0481
Mannan-binding function 3.2.1.78
CBM5,GH18 BPSEU7765_1720 Chitin-binding + chitinase 3.2.1.14
CE1 BPSEU7765_0445, BPSEU7765_0719,
BPSEU7765_0668, BPSEU7765_237,
BPSEU7765_0946, BPSEU7765_1790
Acetylxylan esterase, feruloyl esterase 3.1.1.72, 3.1.1.73
GH73 BPSEU7765_0412, BPSEU7765_0512 Mannosyl-glycoproteinendo-β-N-
acetylglucosaminidase
3.2.1.96
GH99 BPSEU7765_0611 Glycoprotein endo-α-1,2-mannosidase 3.2.1.130
GT26 BPSEU7765_0430, BPSEU7765_1630 UDP-ManNAc:
β-N-acetyl-mannosaminyltransferase
2.4.1.-
GH72 BPSEU7765_0266, BPSEU7765_0695 β-1,3-glucanosyltransglycosylase 2.4.1.-
CBM32 BPSEU7765_1665 N-acetylglucosaminidase 3.2.1.-
CBM2 BPSEU7765_0002, BPSEU7765_0052,
BPSEU7765_1213, BPSEU7765_1468,
BPSEU7765_1666
Chitin, xylan, or cellulose-binding function 3.2.1.4
CE10 BPSEU7765_0058, BPSEU7765_1710,
BPSEU7765_1712
Arylesterase, carboxyl esterase 3.2.1.3
CBM35 BPSEU7765_0482, BPSEU7765_1803 Xylan-degrading enzyme 3.2.1.-
GH39 BPSEU7765_0340, BPSEU7765_0711,
BPSEU7765_1241
A-L-iduronidase, β-xylosidase 3.2.1.76, 3.2.1.37
CBM48, GH13,
CBM41
BPSEU7765_0825 Glycogen-binding function, α-amylase,
α-glucansbinding
2.4.1.18, 3.2.1.1
GH53 BPSEU7765_0174, BPSEU7765_0476,
BPSEU7765_1512, BPSEU7765_1516
Endo-β-1,4-galactanase 3.2.1.89
GH76 BPSEU7765_0339 α-1,6-mannanase 3.2.1.101
GH17 BPSEU7765_0112, BPSEU7765_0403,
BPSEU7765_1389, BPSEU7765_1461
Glucan endo-1,3-β-glucosidase, glucan
1,3-β-glucosidase
3.2.1.39, 3.2.1.58
GT30 BPSEU7765_0219, BPSEU7765_0420,
BPSEU7765_0721
α-3-deoxy-D-manno-octulosonic-acid (KDO)
transferase
2.4.99.-
CE11 BPSEU7765_0715 UDP-3-0-acyl N-acetylglucosamine deacetylase 3.5.1.-
CBM48 BPSEU7765_0051, BPSEU7765_0971,
BPSEU7765_1747
Glycogen-binding function 2.4.1.18
GH4 BPSEU7765_1427 α-glucuronidase, α-galacturonase, α-glucosidase 3.2.1.139, 3.2.1.67, 3.2.1.22
GT81 BPSEU7765_0619 NDP-Glc: glucosyl-3-phosphoglycerate synthase 2.4.1.-
GT34 BPSEU7765_0063 UDP-Gal:
galactomannanα-1,6-galactosyltransferase
2.4.1.-
GT49 BPSEU7765_0521 β-1,3-N-acetylglucosaminyltransferase 2.4.1.-
CBM13 BPSEU7765_0179, BPSEU7765_1749 Xylanase A and arabinofuranosidase function 3.2.1.8
GT5 BPSEU7765_0500, BPSEU765_0962 ADP-Glc: starch glucosyltransferase 2.4.1.21
GH16 BPSEU7765_0806 Xyloglucosyltransferase, keratan-sulfate
endo-1,4-β-galactosidase
2.4.1.207, 3.2.1.103
GH92 BPSEU7765_0869, BPSEU7765_1035,
BPSEU7765_1492
Mannosyl-oligosaccharide α-1,2-mannosidase 3.2.1.113
GT47 BPSEU7765_0074 Xyloglucan β-galactosyltransferase,
heparanβ-glucuronyltransferase
2.1.1.-, 2.4.1.225
CBM20 BPSEU7765_0263 Granular starch-binding function 2.4.1.-, 3.2.1.-
GT66 BPSEU7765_1197 Dolichyl-diphosphooligosaccharide—protein
glycotransferase
2.4.99.18
GH84 BPSEU7765_1279 N-acetyl β-glucosaminidase 3.2.1.52
GT80 BPSEU7765_0408 β-galactoside α-2,6-sialyltransferase 2.4.99.1
GH103 BPSEU7765_0791 Peptidoglycan lytic transglycosylase 3.2.1.-
was originally isolated from the stools of healthy breast-fed
infants (Cano et al., 2013). The ability of this strain to occupy
this niche and out-compete other colonizers could be explained
by its adaptation to utilize a wide variety of oligosaccharides.
Although, breast-milk composition is much more complex
and oligo-galactose as such has only been found in small
amounts in human milk (Scientific Committee on Food, 2003),
human-milk oligosaccharides could promote growth in vivo
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similarly to that observed in vitro when glucose is replaced by
GOS-Lu.
Exploratory Analysis of the
GOS-Lu-Associated Transcriptome
An exploratory RNA-seq approach has been used to analyze
trends in differential gene expression in B. pseudocatenulatum
CECT 7765 genome in response to either glucose or GOS-
Lu as carbon source during anaerobic fermentation. With
this approach, we detected transcripts in more than 99.3%
of the coding genes initially predicted to be encoded by the
B. pseudocatenulatum CECT 7765 genome, leaving sequence
reads for just 12 genes unmapped. Globally, we wanted to
explore potential signals of differential expression on the
basis of measuring the GOS-Lu/glucose ratio of transcripts,
thereby pinpointing the likely genomic regions responsible for
GOS-Lu uptake and metabolism (Figure 3). This exploratory
analysis showed that 76 different genes had a trend of up-
regulation (GFOLD score ≥ 1) when GOS-Lu was used
FIGURE 3 | Exploratory RNA-seq analysis throughout the B. pseudocatenulatum CECT 7765 genome. A single-replicated RNA-seq approach, using
pooled samples, was used to detect genomic regions displaying up- and down-regulation trends in response to GOS-Lu. Gene expression bias based on
normalized GOS-Lu/Glucose ratios obtained from GFOLD analysis (see methods) is presented across the B. pseudocatenulatum CECT 7765 genome. Inner dashed
lines indicate threshold to consider a likely up- or down-regulation (GFOLD score ≤ −1 or ≥1, p < 0.01). Clustered genes showing clear over-expression or
down-regulation are highlighted in black or gray ovals. Tags of genes present in those regions are annotated in the text boxes at the top. The specific genetic
structure of the gene cluster exhibiting the strongest expression change associated with GOS-Lu fermentation is shown below, with the respective KEGG-based
functional annotation for each gene.
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as carbon source (Table 2) whereas 25 genes exhibited a
tendency toward down-regulated (GFOLD score ≤ −1)
under the same condition (Table 3). Altogether, we found
five different gene clusters probably associated with GOS-Lu
fermentation (see gene tags at top of Figure 3), which may
represent a molecular signature for bacteria able to metabolize
this carbon source. Interestingly, among these genes, there
were membrane and periplasmic permeases as well as ABC
transporters, beta-galactosidases, oligosaccharide metabolic
enzymes, and transcriptional regulators, potentially associated
with GOS-Lu fermentation (see functional annotation in
Table 2). We found that B. pseudocatenulatum CECT 7765
genome encodes a total of seven different beta-galactosidases
(BPSEU7765_0525, BPSEU7765_1410, BPSEU7765_1435,
BPSEU7765_1462, BPSEU7765_1517, BPSEU7765_1518,
and BPSEU7765_1737), and five of these showed and
indication to be over-expressed in the presence of GOS-
Lu. Conversely, the BPSEU7765_1410 gene showed a signal
for down-regulation (−1.82) and BPSEU7765_1737 had a
neutral score for potential up- or down-regulation. This
would suggest this couple of encoded enzymes may not be
specific for GOS-Lu utilization. In addition to these likely
expression patterns for beta-galactosidase genes, at least 20
different transporters/permeases seemed to be involved in
GOS-Lu uptake (Table 2). Particularly, the BPSEU7765_0523
and BPSEU7765_0524 ABC-type multiple sugar permeases
showed an important over-expression trend under GOS-Lu
exposure as compared to glucose in the medium. The cluster
of genes BPSEU7765_0522 to BPSEU7765_0527 showed the
strongest indication of over-expression in the presence of the
prebiotic tested (Figure 3; Table 2) and, therefore, they may
potentially be the main elements mediating GOS-Lu uptake
and utilization. This cluster would be primarily regulated
by the BPSEU7765_0522 gene encoding for a LacI-type
transcriptional regulator, which would simultaneously control
expression of sugar transporters/importers (BPSEU7765_0523,
BPSEU7765_0524, and BPSEU7765_0527) and the glycosyl
hydrolases (BPSEU7765_0525 and BPSEU7765_0526).
As a result of the above preliminary and exploratory RNA-
seq analysis, five genes were selected to confirm over-expression.
These were the BPSEU7765_0088 and BPSEU7765_0773 genes,
which would participate in the BCAA metabolism according to
KEGG annotation; and the BPSEU7765_0523, BPSEU7765_0525,
and BPSEU7765_1462 genes, related to sugar metabolism
(Tables 1 and 2). In all cases, their up-regulation was
confirmed by qPCR experiments indicating a high expression
level associated with GOS-Lu consumption (Figure 4). Linear
regression analysis with GFOLD scores against RQ values for
those genes tested indicated that there is a good correlation
among results from both type of analyses (Pearson’s r = 0.73).
Metabolic Processes Likely Activated by
GOS-Lu
Based on the functional annotation of the genes potentially
over-expressed with GOS-Lu as carbon source, according to
the exploratory RNA-seq approach, we identified the metabolic
pathways presumably activated during its fermentation using
the KEGG module-based annotation. We observed fourteen
different pathways/modules represented by the genes exhibiting
a likely up-regulation. As expected, we detected probable
activation of genes involved in galactose degradation (KEGG
Module M00632) and saccharide, polyol, and in lipid transport
(M00196, M00199, M00491, and M00207 modules). When GOS-
Lu was used as carbon source we detected a tendency of over-
expression in a wide variety of oxidoreductases, which would
control and protect against oxidative stress by regulating NAD+,
NADP+, or H2O2 levels in B. pseudocatenulatum CECT 7765.
Likewise, we also detected over-expression signals for several
genes responsible for DNA repair, which probably counteract
potential DNA damage from ROS (oxygen-reactive species)
produced by central metabolism and metabolic byproducts.
Additionally, we observed that GOS-Lu would promote the
expression of genes coding for the biosynthesis of purine and
pyrimidines (M00049, M00050, and M00053 modules) and
branched-chain amino acid (BCAAs = V, L, and I; M00019
and M00570 modules). Moreover, we detected a probable over-
expression of pyruvate kinase (K00873), a key component of the
machinery for carbohydrate degradation which is responsible for
phosphoenolpyruvate (PEP) production, the common precursor
of reduction pathways that produce short-chain fatty acids
(SCFAs) (den Besten et al., 2013). In order to confirm
our preliminary findings, further supported by qPCR results
showing a strong over-expression in the BPSEU7765_0088 and
BPSEU7765_0773 genes associated to BCAA metabolism, we also
measured the metabolic output of the BCAA metabolic pathways
over-expressed during GOS-Lu fermentation. We measured
BCAA released to the extracellular media during growth in
the presence of either glucose or GOS-Lu, using LC and OPA-
derivatization (Table 4). We found an increase in all BCAA
in the cell-free supernatants of B. pseudocatenulatum CECT
7765 cultures supplemented with GOS-Lu as carbon source,
but only differences in leucine concentrations were significant
(p ≤ 0.0371). Leucine concentrations were more than 11%
higher in the supernatants of GOS-Lu cultures than in the
supernatants of glucose cultures. B. pseudocatenulatum CECT
7765 was shown to ameliorate the metabolic and immune
dysfunction of diet-induced obesity in mice, partly by reducing
lipid absorption and exerting an anti-inflammatory effect (Cano
et al., 2013; Moya-Perez et al., 2015). According to our present
findings, the combination of this strain with GOS-Lu could
theoretically mediate another beneficial effect against obesity via
generation of leucine, given the role of this amino acid as nutrient
sensor and inducer of satiety (Potier et al., 2009; Schwartz,
2013).
Finally, some genes presented in the SP5 also exhibited
an over-expression sign as a result of GOS-Lu fermentation.
Thus, the corresponding predicted ORFs BPSEU7765_1612 and
BPSEU7765_1613 would appear to be associated with GOS-Lu
consumption by B. pseudocatenulatum CECT 7765. Although
no functional information could be inferred for those genes
according to databases, their genomic context suggests their
involvement in sugar-nucleotide metabolism, given that they are
flanked by ABC-MS multiple sugar transporters, a UPD glucose
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TABLE 2 | List of B. pseudocatenulatum CECT 7765 up-regulated genes during GOS-Lu fermentation.
Gene tag Functional annotation1 GFOLD score2 Description
BPSEU7765_0064 K01362 1.41 Trypsin-like peptidase
BPSEU7765_0087 PF07690 2.35 MFS, ABC membrane transporter
BPSEU7765_0088 K00053 1.41 ilvC, ketol-acid reductoisomerase
BPSEU7765_0113 K07243 2.54 FTR, efeU, high-affinity iron transporter
BPSEU7765_0114 PF10634 2.41 Iron periplasmic transporter
BPSEU7765_0115 No hits 1.85 Unknown function
BPSEU7765_0116 K09808 1.57 ABC lipoprotein-releasing system permease
BPSEU7765_0117 No hits 1.40 Unknown function
BPSEU7765_0118 PF12704 1.56 MacB, FtsX, periplasmic ABC transporters
BPSEU7765_0119 K02003 1.59 ABC transport system
BPSEU7765_0120 SM000900 1.28 FMN binding, membrane Na(+) pump
BPSEU7765_0125 K06191 2.13 nrdH, glutaredoxin-like protein
BPSEU7765_0190 K06910 1.33 Phosphatidylethanolamine-binding protein
BPSEU7765_0191 K08659 1.24 pepDA, pepDB, dipetidase
BPSEU7765_0327 K02346 1.96 dinB, DNA polymerase IV
BPSEU7765_0395 No hits 1.09 Unknown function
BPSEU7765_0419 K01784 1.00 galE, UDP-glucose 4-epimerase
BPSEU7765_0522 K02529 2.71 lacI, galR, LacI family transcriptional regulator
BPSEU7765_0523 K02025 4.24 ABC MS P, multiple sugar transport permease
BPSEU7765_0524 K02026 4.03 ABC MS P1, multiple sugar transport permease
BPSEU7765_0525 K12308 3.46 bgaB, lacA, beta-galactosidase
BPSEU7765_0526 K01209 4.19 abfA, alpha-N-arabinofuranosidase
BPSEU7765_0527 K10188 3.99 lacE, araN, lactose/L-arabinose transporter
BPSEU7765_0593 K03502 1.49 umuC, DNA polymerase V
BPSEU7765_0773 K00873 1.37 Pyk, pyruvate kinase
BPSEU7765_0810 No hits 1.20 Unknown function
BPSEU7765_0811 PF12704 1.56 MacB, FtsX, periplasmic ABC transporters
BPSEU7765_0812 K02003 1.52 ABC transport system
BPSEU7765_0828 K09014 1.24 sufB, Fe–S cluster assembly protein
BPSEU7765_0829 K09015 1.00 sufD, Fe–S cluster assembly protein
BPSEU7765_0831 K11717 1.14 sufS, cysteine desulfurase
BPSEU7765_0850 K06191 2.07 nrdH, glutaredoxin-like protein
BPSEU7765_0851 K03647 2.25 nrdI, protein involved in ribonucleotide reduction
BPSEU7765_0852 K00525 2.51 nrdA, nrd Eribonucleosid-diphosphate reductase
BPSEU7765_0853 No hits 2.63 Unknown function
BPSEU7765_0854 K00526 2.22 nrdB, nrdF, ribonucleosid-diphosphate reductase
BPSEU7765_0931 K01442 1.09 Choloylglycine hydrolase
BPSEU7765_0932 PF09819 1.18 ABC-type cobalt transporter
BPSEU7765_0954 K03701 1.28 uvrA, excinuclease ABC subunit A
BPSEU7765_1031 PF07690 1.01 ABC membrane small-molecule transporter
BPSEU7765_1086 K03593 1.41 mrp, Chromosome partition ATP-binding protein
BPSEU7765_1204 K03724 1.30 lhr, ATP-dependent helicase
BPSEU7765_1220 K03553 1.11 recA, recombination protein
BPSEU7765_1231 No hits 1.56 Unknown function
BPSEU7765_1285 K02565 1.95 nagC, N-acetylglucosamine repressor
BPSEU7765_1286 K00847 1.40 scrK, fructokinase
BPSEU7765_1304 SM000257 2.48 LysM, bacterial cell wall degradation
BPSEU7765_1305 K01356 1.90 lexA, repressor LexA
BPSEU7765_1389 K11104 1.50 melB, melibiose permease
BPSEU7765_1435 K01190 1.55 lacZ, beta-galactosidase
BPSEU7765_1461 K11104 2.61 melB, melibiose permease
BPSEU7765_1462 K01190 3.29 lacZ, beta-galactosidase
(Continued)
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TABLE 2 | Continued
Gene tag Functional annotation1 GFOLD score2 Description
BPSEU7765_1463 PF00356 2.89 lacI, galR, LacI family transcriptional regulator
BPSEU7765_1464 K02529 1.82 lacI, galR, LacI family transcriptional regulator
BPSEU7765_1466 K00384 1.05 trxB, thioredoxin reductase
BPSEU7765_1467 K03386 1.52 ahpC, peroxiredoxin (hydroperoxide reductase)
BPSEU7765_1517 K12308 1.21 bgaB, lacA, beta-galactosidase
BPSEU7765_1518 K12308 1.48 bgaB, lacA, beta-galactosidase
BPSEU7765_1519 K02026 1.16 ABC MS P1, multiple sugar transport permease
BPSEU7765_1520 K10118 2.21 msmF, raffinose/stachyose/melibiose transporter
BPSEU7765_1521 K10117 2.41 msmE, raffinose/stachyose/melibiose transporter
BPSEU7765_1524 K06148 1.15 ABCC-BAC transporter
BPSEU7765_1552 K07749 2.51 frc, formyl-CoA transferase
BPSEU7765_1553 K07088 3.74 Membrane transport protein
BPSEU7765_1554 K01577 3.95 Oxc, oxalyl-CoA decarboxylase
BPSEU7765_1555 No hits 1.02 Unknown function
BPSEU7765_1577 K09760 1.76 rmuC, DNA recombination protein
BPSEU7765_1579 K03695 1.69 clpB, ATP-dependent Clp protease
BPSEU7765_1612 No hit 1.58 Unknown function
BPSEU7765_1613 No hit 1.34 Unknown function
BPSEU7765_1649 K00965 1.03 galT, UDPglucose-1-phosphate urydyltransferase
BPSEU7765_1673 K17686 1.51 copA, Cu+ exporting ATPase
BPSEU7765_1722 K02529 1.50 lacI, galR, LacI family transcriptional regulator
BPSEU7765_1733 K02025 1.66 ABC MS P, multiple sugar transport permease
BPSEU7765_1766 K15770 1.18 ganO, maltooligosaccharideoligomertransporter
BPSEU7765_1768 K00705 1.10 malQ, 4-alpha-glucanotransferase
1Functional annotation primarily presented from KEGG, when KEGG Orthology (KO) assignment is lacking, SMART or Pfam domain architecture is presented (SM or PF
codes, respectively). 2The GFOLD analysis can detect potential trends of gene expression in unreplicated data but require further evaluation by other methods such as
qPCR. A GFOLD score other than zero indicates probable differential expression between two genes under two different conditions, an inference based on Bayesian
probabilities of log2 fold-change per gene across the genome (p = 0.01; Feng et al., 2012). Threshold for selection of probable up-regulated genes was ≥1 whereas
GFOLD values ≤1 were set for selecting genes likely down-regulated during GOS-Lu fermentation.
6-dehydrogenase, a dTDP glucose 4,6-dehydratase, an alpha-D-
xylose xylohydrolase, and a lactose/L-arabinose transporter.
GOS-Lu Species Preferentially
Consumed by B. pseudocatenulatum
CECT 7765
To further integrate metabolic data resulting from GOS-Lu
fermentation by B. pseudocatenulatum CECT 7765, we measured
the concentrations of derivated mono-, di-, and trisaccharides
at baseline and after growth in the presence of GOS-Lu.
We observed preferential utilization of saccharide species and,
particularly, the disaccharide fraction. Specifically, consumption
of disaccharides was estimated at 70% and the trisaccharide
fraction decreased by about 37% on average (Table 5).
Additionally, we found that the extracellular concentration of
monosaccharide components of lactulose increased by 30–40%
(fructose and galactose, respectively; Table 5). This observation
can be explained by presence of glycosyl hydrolases anchored to
the cell-wall surface. To test this, we searched for an amino acid
motif in the 252 CAZy enzymes detected in B. pseudocatenulatum
CECT 7765 (Table 1) using the ScanProsite server (de Castro
et al., 2006) and the amino acid patterns recognized by sortase
enzymes, responsible for covalent attachment of proteins to
cell-wall surface in Gram-positive bacteria. We did not find
any enzymes harboring the amino acid pattern associated with
sortase B activity N-P-[QK]-T-N, but we did find five enzymes
containing the extended amino acid pattern recognized by sortase
A proteins [LPSN]-[PAG]-X-T-G (Ton-That et al., 2004; van
Leeuwen et al., 2014). Among these, only one harbored a glycosyl
hydrolase domain, encoded by the gene BPSEU7765_0825 (S-
A-I-T-G motif at C-ter). Although, the above analysis could
explain the increased concentration of monosaccharides in the
extracellular medium, we cannot discount the potential release
of intracellular glycosylhydrolases to the culture medium due
to spontaneous cell lysis during culture and/or supernatant
preparation. The main GOS-Lu species largely consumed by
B. pseudocatenulatum CECT 7765 were lactulose, 1,4-galactosyl-
[1, 1-galactosyl]-fructose and 6′ galactosyl-lactulose, which
decreased by 71, 47, and 31%, respectively, after incubation.
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TABLE 3 | List of B. pseudocatenulatum CECT 7765 down-regulated genes during GOS-Lu fermentation.
Gene tag Functional annotation1 GFOLD score2 Description
BPSEU7765_0182 K01854 −1.11 glf, UDP-galactopyranose mutase
BPSEU7765_0187 K02529 −1.97 lacI, galR, LacI family transcriptional regulator
BPSEU7765_0188 PF00381 −3.48 PTS carbohydrate transport system
BPSEU7765_0189 K08483 −3.92 PTS-EI, ptsI phosphotransferase system
BPSEU7765_0386 K02757 −4.60 PTS-Bgl beta-glucosidase-specific IIC component
BPSEU7765_0387 K03488 −2.81 bglG, beta-glucosidasetranscriptionalantiterminator
BPSEU7765_0478 K02025 −1.00 ABC MS P, multiple sugar transport permease
BPSEU7765_0586 K01817 −2.13 trpF, phophoribosylanthranilate isomerase
BPSEU7765_0587 K13954 −2.34 yiaY, alcohol dehydrogenase
BPSEU7765_0588 K01239 −2.77 iunH, purine nucleosidase
BPSEU7765_0589 PF07690 −2.59 ABC membrane small-molecule transporter
BPSEU7765_1024 No hits −1.72 Unknown function
BPSEU7765_1408 PF07690 −1.35 ABC membrane small-molecule transporter
BPSEU7765_1410 K12308 −1.82 bgaB, lacA, beta-galactosidase
BPSEU7765_1458 K02003 −1.09 ABC transport system
BPSEU7765_1459 K02004 −1.05 ABC transport system permease
BPSEU7765_1596 K00852 −1.24 rbsK, ribokinase
BPSEU7765_1626 K10188 −3.89 lacE, araN, lactose/L-arabinose transporter
BPSEU7765_1627 K02025 −3.13 ABC MS P, multiple sugar transport permease
BPSEU7765_1628 K02026 −3.04 ABC MS P1, multiple sugar transport permease
BPSEU7765_1629 K01238 −1.39 Glycosyl hydrolase
BPSEU7765_1724 K02564 −1.08 nagB, glucosamine-6-phosphate deaminase
BPSEU7765_1725 K12373 −1.10 HEXA, hexosaminidase
BPSEU7765_1776 PF13416 −1.47 Bacterial extracellular solute-binding protein
BPSEU7765_1777 K01187 −1.13 malZ, alpha-glucosidae
1Functional annotation primarily presented from KEGG, when KEGG Orthology (KO) assignment is lacking, SMART or Pfam domain architecture is presented (SM or PF
codes, respectively). 2The GFOLD analysis can detect potential trends of gene expression in unreplicated data but require further evaluation by other methods such as
qPCR. A GFOLD score other than zero indicates probable differential expression between two genes under two different conditions, an inference based on Bayesian
probabilities of log2 fold-change per gene across the genome (p = 0.01; Feng et al., 2012). Threshold for selection of probable up-regulated genes was ≥1 whereas
GFOLD values ≤1 were set for selecting genes likely down-regulated during GOS-Lu fermentation.
FIGURE 4 | Gene expression by qPCR. The data derived from preliminary
and exploratory RNA-seq approach for genes BPSEU7765_0088,
BPSEU7765_0523, BPSEU7765_0525, BPSEU7765_0773, and
BPSEU7765_1462 was used as starting point to evaluate their
over-expression by relative quantification in a qPCR assay. RQ ± SEM values
are presented for all genes analyzed using three independent replicates per
treatment and the average expression under glucose exposure as reference
(see RQ ∼ 1 for these samples). In all cases the differential expression was
significantly higher in samples from cultures with GOS-Lu (RQ > 5) than in
those with glucose (p ≤ 0.05).
Additionally, other less predominant GOS-Lu species were also
largely consumed, thus the disaccharides 1,4-galactobiose (E +
Z isomers), 1,5-galactosyl-fructose, and 1,6-galactobiose were
consumed at levels above 80%.
DISCUSSION
We have assembled the draft genome of B. pseudocatenulatum
CECT 7765 using DNA sequence analysis of high-throughput
sequencing data. This bifidobacterial strain was isolated from
a breast-fed infant, and shows preclinical efficacy preventing
obesity and metabolic dysfunction. Through comparative
genomics we have detected certain strain-specific genome
regions in B. pseudocatenulatum CECT 7765 indicating a
gain-of-function associated with carbohydrate uptake and
metabolism. Further features found in the B. pseudocatenulatum
CECT 7765 chromosome are indicative of its genome stability,
for example regarding protection against phage infections.
These traits are generally considered relevant for potential
probiotic applications. In particular, we have disclosed four
restriction modification systems, a CRISPR system, and a system
to abort phage infections. To our knowledge, bifidobacteria
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usually present up to three restriction modification systems
(O’Connell Motherway et al., 2009, 2014), which means
that B. pseudocatenulatum CECT 7765 would be the first
bifidobacteria harboring a larger collection of such defense
mechanisms. Regarding the number of enzymes related to
saccharide metabolism, the CAZy annotation system (Lombard
et al., 2014) showed us that B. pseudocatenulatum CECT
7765 contains a larger set of these proteins when compared
with complete genomes of close species. Sixty-seven of the
252 CAZy enzymes detected in the B. pseudocatenulatum
CECT 7765 genome were found to be exclusive to this
strain when compared with the genetic information of close
species, and they were grouped into 33 different CAZy
families.
TABLE 4 | Quantification of extracellular BCAAs after GOS-Lu fermentation.
Amino Acid Reference
glucoseab
Reference
GOS-Luab
Glucose culturec GOS-Lu culturec Differenced
(%)
Significance
(p-value)
BCAAs Valine 315 ± 5 280 ± 40 332 ± 18 (1.053) 302 ± 12 (1.077) 2.32 0.3702
Isoleucine 230 ± 10 215 ± 25 213 ± 12 (0.928) 202 ± 8 (0.938) 1.13 0.4370
Leucine 700 ± 1 690 ± 10 697 ± 50 (0.929) 713 ± 29 (1.034) 11.33 0.0371
BCAAs, branched-chain amino acids; GOS-Lu, lactulose-derived galacto-oligosaccharides. aData are mean (n = 3) ± SEM and expressed in ppm (part per million).
bReference samples consist in culture media before cell inoculum. cValues within parenthesis mean normalized values against reference values. dDifference is calculated
as [GOS-Lu/Glucose]-1 and described in percentage.
TABLE 5 | Quantification of GOS-Lu species before (Pre) and after (Post) incubation with B. pseudocatenulatum CECT 7765.
Concentration, mg/mL
Saccharide species Retention time (min) GOS-Lu pre GOS-Lu post GOS-Luc change
Monosaccharides Fructose 6.6 0.07 (0.02)a 0.09 (0.00) +29
Galactose 7.1 0.05 (0.02) 0.07 (0.02) +40
Glucose 7.2 0.009 (0.002) 0.003 (0.001) −67
Disaccharides Lactulose 14.9 0.93 (0.08) 0.27 (0.15) −71
1,4-galactobiose Eb 15.2 0.010 (0.001) 0.001 (0.001) −90
1,5-galactosyl-fructose 1 15.3 0.016 (0.001) 0.001 (0.001) −83
1,5-galactosyl-fructose
2+1,3-galactobiose E
15.4 0.05 (0.00) 0.02 (0.01) −60
1,2 galactobiose E + unknown 15.6 0.028 (0.002) 0.010 (0.003) −64
1,4 galactobiose Z 16.0 0.012 (0.001) 0.003 (0.002) −75
1,2 galactobiose Z + 1,3
galactobiose Z
16.3 0.008 (0.001) 0.003 (0.001) −63
1,6 glucosyl-fructose 1 16.7 0.004 (0.001) 0.001 (0.001) −75
1,6 glucosyl-fructose 2 16.8 0.003 (0.001) 0.001 (0.001) −67
1,1,galactosyl-fructose 17.1 0.016 (0.001) 0.005 (0.003) −69
1,6 galactobiose E + 1,1
galactosyl-fructose
17.4 0.04 (0.01) 0.02 (0.01) −50
1,6 galactobiose Z 18.4 0.005 (0.001) 0.001 (0.001) −80
Trisaccharides Unknown 32.6 0.011 (0.002) 0.007 (0.001) −36
Unknown 33.2 0.015 (0.001) 0.011 (0.002) −27
Unknown 34.5 0.019 (0.005) 0.012 (0.001) −37
Unknown 34.7 0.10 (0.03) 0.04 (0.01) −60
6′ galactosyl-lactulose 1 35.0 0.20 (0.05) 0.15 (0.03) −25
6′galactosyl-lactulose 2 35.4 0.33 (0.05) 0.21 (0.03) −37
1,4-galactosyl- [1,
1-galactosyl]-fructose +
unknown
35.8 0.17 (0.03) 0.09 (0.01) −47
Unknown 36.2 0.02 (0.01) 0.010 (0.001) −50
Unknown 36.5 0.003 (0.001) 0.002 (0.002) −33
Unknown 38.6 0.02 (0.01) 0.01 (0.02) −50
aStandard deviation in parenthesis (n = 3). bReducing carbohydrates gives rise to two peaks corresponding to the TMS oximes of syn (E) and anti (Z) isomers after
derivatization. cReduction or increase in GOS-Lu mono-, di-, and tri-saccharide species was calculated as the relative percentage of the final concentration of those
saccharides (GOS-Lu post) compared to their initial concentration (GOS-Lu pre), respectively.
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An exploratory RNA-seq analysis using pooled samples
enabled stool identify potential genes responsible for GOS-Lu
fermentation, encoding a wide variety of sugar transporters
and permeases. Also, the expression of five out of seven
beta-galactosidases present in the B. pseudocatenulatum CECT
7765 genome was identified to be likely associated with
GOS-Lu fermentation. The over-expression trend observed
for some of those genes was further assessed through a
qPCR approach. As a result, we confirmed the over-expression
of the BPSEU7765_0088, BPSEU7765_0773, BPSEU7765_0523,
BPSEU7765_0525, and BPSEU7765_1462 genes in response to
GOS-Lu consumption. This fact, and the strong correlation
between GFOLD scores and RQ values obtained for the
respective genes, would confirm the reliability of the findings
from the exploratory transcriptome analysis, as a result of the
GOS-Lu consumption by B. pseudocatenulatum CECT 7765.
Particularly, we found a specific gene cluster (BPSEU7765_0522
to BPSEU7765_0528 genes) that was strongly over-expressed
when GOS-Lu was used as carbon source. Taking into account
the pattern of GOS-Lu species consumption, we hypothesized
this gene cluster could be directly involved in controlling the
import and hydrolysis of di- and tri-saccharides shown to be
preferentially taken-up by B. pseudocatenulatum CECT 7765.
In addition, the functions of the probable over-expressed genes
have been mapped to the main bacterial metabolic pathways
using the KEGG hierarchical classification. We found that GOS-
Lu fermentation would activate galactose, saccharide and polyol
degradation, lipid transport, antioxidant response, DNA repair
processes, and purine/pyrimidine and BCAA biosynthesis. We
corroborated the specific response of these genes to GOS-
Lu, demonstrating that GOS-Lu fermentation boosts leucine
synthesis and release, by directly analyzing the metabolic
products generated and performing qPCR of some of the
transcripts tentatively over-expressed in the exploratory RNA-
seq analysis. Therefore, the use of GOS-Lu could contribute
to promoting B. pseudocatenulatum CECT 7765 growth in the
gut and, additionally, the molecular and metabolic outputs
obtained from these synbiotic interactions indicate its likely
beneficial anti-obesity effects. These effects could be related
to the role of leucine as nutrient sensor and inducer of
satiety, via activation of the mTOR-S6K signaling pathway
on the hypothalamus, which would promote expression of
anorexigenic peptides (Schwartz, 2013). Nevertheless, the extent
to which amino acids produced by intestinal bacteria can
confer health benefits to the human host in vivo has yet to be
demonstrated.
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